Table 3. Distinctive characteristics and clues to the diagnosis of the autoinflammatory diseases.
| FMF | PAPA | ||
|
|
||
| HIDS | Early-onset IBD | ||
|
|
||
| TRAPS | DITRA | ||
|
|
||
| CAPS/FCAS | CAMPS | ||
|
|
||
| CAPS/MWS | PRAAS | ||
|
|
||
| CAPS/NOMID | PLAID | ||
|
|
||
| PGA | APLAID | ||
|
|
||
| DIRA | HOIL-1 DEFICENCY | ||
|
|
||
| Majeed syndrome | |||
|
|||
CAPS: cryopyrin asscoiated periodic syndrome; NOMID: neonatal-onset multisystem inflammatory disease; MWS: Muckle-Wells syndrome; FCAS: familial cold autoinflammatory syndrome; FMF: familial Mediterranean fever; HIDS: hyperimmunoglobulinemia D syndrome with periodic fever; TRAPS: TNF receptor associated periodic syndrome; PGA: pediatric granulomatous arthritis; DIRA: deficiency of interleukin 1 receptor antagonist; PAPA: pyogenic arthritis, pyoderma gangrenosum and acne syndrome; EO-IBD: early-onset inflammatory bowel disease; DITRA: deficiency of interleukin 36 receptor antagonist; CAMPS: CARD14 mediated psoriasis; PRAAS: proteasome associated autoinflammatory syndromes;PLAID: PLCγ2-associated antibody deficiency and immune dysregulation; APLAID: autoinflammation and PLCγ2-associated antibody deficiency and immune dysregulation;